SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001169245-22-000118
Filing Date
2022-11-15
Accepted
2022-11-15 16:21:01
Documents
4
Period of Report
2022-09-30
Effectiveness Date
2022-11-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q nt10-qq32022111522.htm NT 10-Q 6250
2 GRAPHIC nt10-qq32022111522001.jpg GRAPHIC 107306
3 nt10-qq32022111522002.jpg GRAPHIC 165966
4 nt10-qq32022111522003.jpg GRAPHIC 89339
  Complete submission text file 0001169245-22-000118.txt   507169
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 221391413
SIC: 2834 Pharmaceutical Preparations